Fewer Elderly Patients with Moderate-to-Severe Chronic Pain Discontinue Tapentadol Extended-Release vs Oxycodone Controlled-Release Due to Adverse Events - ONA
Links shared publicly online about this topic.
- 1,183total visits
Fewer Elderly Patients with Moderate-to-Severe Chronic Pain Discontinue Tapentadol Extended-Release vs Oxycodone Controlled-Release Due to Adverse Events - ONA
View full resource at oncologynurseadvisor.com
Tags: Pain Medication, Pain, Chronic Pain, Drug, Senior Health, Oxycontin, Roxicodone, Event
Most Recently Shared on May 8, 2010 at 1:48 pm By:
Fewer Elderly Patients with Moderate-to-Severe Chronic Pain Discontinue Tapentadol Extended… http://goo.gl/fb/DK60M
Fewer Elderly Patients with Moderate-to-Severe Chronic Pain Discontinue Tapentadol Extended-Release vs Oxycodone Controlled-Release Due to Adverse Events - MPR
empr.com — “Tapentadol extended-release (ER), an investigational drug, was associated with better gastrointestinal tolerability in elderly patients with moderate-to-severe chronic pain, with fewer discontinuing the study due to treatment-emergent adverse events (TEAEs) than oxycodone controlled-release (CR), investigators concluded in a presentation during the 29th Annual Scientific Meeting of the American Pain Society.” View full resource at empr.com
Most Recently Shared on May 8, 2010 at 2:42 pm By:
APS: Fewer Elderly Patients with Moderate-to-Severe Chronic Pain Discontinue Tapentadol Extended-Release vs Oxycod... http://bit.ly/9yMFpG
Advertisement
